Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 12 de 12
Filter
1.
Reprod Fertil Dev ; 34(17): 1059-1077, 2022 Oct.
Article in English | MEDLINE | ID: mdl-36219878

ABSTRACT

CONTEXT: Tuberculosis is one of the major infectious diseases, with people of reproductive age group having a high risk of infection. AIMS: The present study was designed to understand the consequences of anti-tuberculosis drugs (ATDs) used in DOTS (directly observed treatment short course) schedule on ovarian function. METHODS: Adult female Swiss albino mice were orally administered with combinations of ATDs used in the DOTS schedule every day for 4weeks. At 2weeks after the cessation of ATDs administration, the endocrine changes and ovarian function were assessed in mice. KEY RESULTS: Administration of ATDs to mice resulted in a prolonged estrous cycle, reduced ovarian follicle reserve, alteration in FSH, LH, and progesterone level, and decreased the number of ovulated oocytes. Further, the degree of fragmentation, degeneration, abnormal distribution of cytoplasmic organelles, abnormal spindle organisation, and chromosomal misalignment were higher in oocytes that were ovulated following superovulation. Blastocysts derived from ATDs treated mice had significantly lower total cell numbers and greater DNA damage. A marginal increase in the number of resorbed fetuses was observed in all the ATDs treated groups except in the multidrug resistance treatment group. Male progeny of ATDs treated mice had decreased sperm count and lower progressive motility, while female progeny exhibited a non-significant reduction in the number of oocytes ovulated. CONCLUSIONS: Theresults of this study suggest that ATDs can have significant adverse effects on the ovarian reserve, cytoplasmic organisation of oocytes, and can potentially cause transgenerational changes. IMPLICATIONS: The findings of the present study indicate ovarian toxicity of ATDs and warrant further research in the direction of identifying alternate drugs with minimal toxicity, and strategies to mitigate the ovarian toxicity induced by these drugs.


Subject(s)
Ovarian Reserve , Male , Mice , Female , Animals , Antitubercular Agents/pharmacology , Semen , Oocytes , Superovulation
2.
Toxicol Appl Pharmacol ; 433: 115772, 2021 12 15.
Article in English | MEDLINE | ID: mdl-34715073

ABSTRACT

The cancer therapy using cyclophosphamide (CP) has been associated with adverse effects on the testicular function that raises concerns about the future fertility potential among cancer survivors. Curcumin, a polyphenol, has shown to possess a plethora of biological functions including tissue protective effects. In the present study, we investigated the protective effects of curcumin nanocrystals (NC) in mitigation of CP-induced testicular toxicity. Healthy adult (8-10 week) and prepubertal (2 week) male Swiss albino mice were injected with a single dose of CP (200 mg/kg) intraperitoneally (i.p). NC (4 mg/kg, i.p.) was administered every alternate day, for 35 days in adult mice while, a single dose of NC was injected intraperitoneally to prepubertal mice 1 h prior to CP. Administration of multiple doses of NC ameliorated CP-induced testicular toxicity in adult mice, which was evident from the improved sperm functional competence, sperm chromatin condensation, seminiferous tubule architecture and decreased apoptosis in testicular cells. Further, administration of NC 1 h prior to CP in prepubertal mice modulated the expression of genes pertaining to proliferation, pluripotency, DNA damage and DNA repair in spermatogonial cells at 24 h after the treatment. Overall, these results suggest that NC could be a promising chemoprotective agent, which can have potential application in male fertility preservation.


Subject(s)
Antineoplastic Agents, Alkylating/toxicity , Antioxidants/pharmacology , Curcumin/pharmacology , Cyclophosphamide/toxicity , Nanoparticles , Spermatogonia/drug effects , Testicular Diseases/prevention & control , Testis/drug effects , Animals , Antioxidants/chemistry , Cell Proliferation/drug effects , Curcumin/chemistry , DNA Damage/drug effects , Drug Compounding , Gene Expression Regulation , Infertility, Male/chemically induced , Infertility, Male/metabolism , Infertility, Male/pathology , Infertility, Male/prevention & control , Male , Mice , Oxidative Stress/drug effects , Spermatogonia/metabolism , Spermatogonia/pathology , Testicular Diseases/chemically induced , Testicular Diseases/metabolism , Testicular Diseases/pathology , Testis/metabolism , Testis/pathology , Time Factors
3.
Andrologia ; 53(8): e14115, 2021 Sep.
Article in English | MEDLINE | ID: mdl-34014595

ABSTRACT

Quinalphos (QP) is one of the most commonly used organophosphate pesticide for agriculture. In this study, adult Swiss albino male mice were orally administered with 0.25, 0.5 and 1.0 mg/kg of QP (Ekalux 25 E.C.) for ten consecutive days and the reproductive function was assessed at 35 and 70 days after QP treatment. At highest dose (1.0 mg/kg), QP exposure resulted in significant decrease in motility and increase in sperm head defects and DNA damage. Pharmacokinetic data showed a threefold increase in concentration of QP in the testis as compared to serum. QP was detectable in testes even after 24 hr of administration indicating slow clearance from tissue. In addition, high oestradiol, low testosterone level with a parallel increase in aromatase and cytochrome P450 transcript levels was observed. Significant decrease in fertilisation, lower blastocyst rate and poor blastocyst quality was observed when spermatozoa collected from QP exposed mice were subjected to in vitro fertilisation. In conclusion, exposure of QP to male mice decreases the sperm functional competence and fertilising ability, which appears to be mediated through elevated oxidative stress and altered steroidogenesis in testes.


Subject(s)
Organophosphorus Compounds , Pesticides , Animals , Fertilization , Male , Mice , Organothiophosphorus Compounds , Pesticides/toxicity , Sperm Motility , Spermatozoa , Testis
4.
Reprod Fertil Dev ; 32(14): 1169-1179, 2020 Oct.
Article in English | MEDLINE | ID: mdl-32998795

ABSTRACT

The present study was designed to investigate the effect of diet-induced obesity on endoplasmic reticulum (ER) stress in oocytes. Swiss albino mice (3 weeks old) were fed with a high-fat diet (HFD) for 8 weeks. Oocytes were assessed for lipid droplet accumulation, oxidative stress, ER stress and their developmental potential invitro. High lipid accumulation (P<0.01) and elevated intracellular levels of reactive oxygen species were observed in both germinal vesicle and MII oocytes of HFD-fed mice (P<0.05 and P<0.01 respectively compared with control). Further, expression of the ER stress markers X-box binding protein 1 (XBP1), glucose-regulated protein 78 (GRP78), activating transcription factor 4 (ATF4) and activating transcription factor 6 (ATF6) was significantly (P<0.001) higher in oocytes of the HFD than control group. Oocytes from HFD-fed mice exhibited poor fertilisation and blastocyst rates, a decrease in total cell number and high levels of DNA damage (P<0.01) compared with controls. In conclusion, diet-induced obesity resulted in elevated lipid levels and higher oxidative and ER stress in oocytes, which contributed to the compromised developmental potential of embryos.


Subject(s)
Embryonic Development/physiology , Endoplasmic Reticulum Stress/physiology , Lipid Metabolism/physiology , Oocytes/metabolism , Oxidative Stress/physiology , Activating Transcription Factor 4/metabolism , Activating Transcription Factor 6/metabolism , Animals , DNA Damage , Diet, High-Fat , Endoplasmic Reticulum Chaperone BiP , Female , Heat-Shock Proteins/metabolism , Mice , Obesity/metabolism , Reactive Oxygen Species/metabolism , X-Box Binding Protein 1/metabolism
5.
J Assist Reprod Genet ; 37(5): 1227-1238, 2020 May.
Article in English | MEDLINE | ID: mdl-32335799

ABSTRACT

PURPOSE: Metformin is the most commonly prescribed drug in the management of metabolic disorders such as polycystic ovarian syndrome (PCOS) and gestational diabetes in women of reproductive age. Insulin-sensitizing effect of metformin helps in improving from PCOS features such as hyperandrogenism, anovulation, and infertility. However, its ability to cross placental barrier raises concern about safety of the drug on early embryonic development. In this study, we evaluated the effect of metformin on the ovarian function and embryo development. METHODS: Adult Swiss albino female mice were administered with metformin (0, 50, 100, and 200 mg/kg body weight) for 4 weeks and assessed for reproductive function and preimplantation embryo development. Further, effect of metformin (0, 10, 25, 50, 100, 250, and 500 µg/mL) exposure to 2-cell-stage embryos was tested under in vitro conditions. RESULTS: Metformin did not alter the body weight, blood glucose, ovarian weight, and follicular reserve. However, the early embryo development was significantly affected in mice treated with metformin in vivo at highest dose. Moreover, embryos which were exposed to metformin in vitro showed dose-dependent decline in blastocyst rate and hatching rate. Furthermore, at highest concentration of metformin (500 µg/mL), all the embryos were arrested at compaction stage. CONCLUSION: The study revealed that metformin affects the early embryonic development and raises concern about its use during conception.


Subject(s)
Diabetes, Gestational/drug therapy , Hypoglycemic Agents/pharmacology , Metformin/pharmacology , Polycystic Ovary Syndrome/drug therapy , Adult , Animals , Blastocyst/drug effects , Blood Glucose/drug effects , Diabetes, Gestational/blood , Diabetes, Gestational/physiopathology , Disease Models, Animal , Embryonic Development/drug effects , Female , Fertilization in Vitro/trends , Humans , Hypoglycemic Agents/adverse effects , Insulin/metabolism , Insulin Resistance/genetics , Metformin/adverse effects , Mice , Polycystic Ovary Syndrome/blood , Polycystic Ovary Syndrome/physiopathology , Pregnancy
6.
J Assist Reprod Genet ; 36(2): 255-266, 2019 Feb.
Article in English | MEDLINE | ID: mdl-30284103

ABSTRACT

PURPOSE: Motility of spermatozoa helps not only in planning the type of infertility treatment but also directly reflects the success rate in assisted reproductive technology (ART). Previously, biotin, a water-soluble vitamin, has been shown to increase the motility and longevity of cryopreserved human spermatozoa. The present study was designed to understand the molecular basis of the beneficial effects of presence of biotin in sperm wash medium on early embryo development. METHODS: The effect biotin supplementation to sperm wash medium on the sperm parameters were assessed in swim-up fraction of normozoospermic and asthenozoospermic ejaculates collected from infertile men. Fertilization and early embryo development was studied using Swiss albino mice. RESULTS: Even though both biotin and pentoxifylline (PTX) enhanced the motility of spermatozoa from normozoospermic and asthenozoospermic samples, biotin group exhibited higher in vitro survival. Using mouse model, we observed that presence of biotin or PTX in sperm wash medium improved the fertilization rate and blastocyst rate compared to control. Blastocysts from these groups had significantly higher total cell number (P < 0.01) and lower apoptotic index. In silico target prediction revealed that GTPase HRas (HRas), tyrosine-protein phosphatase nonreceptor type 1 (PTP1B), and glucokinase are the probable targets for biotin. Solution-state Nuclear Magnetic Resonance (NMR) studies confirmed that biotin interacts both with human HRas and PTP1B. CONCLUSION: Our results indicate that presence of biotin in sperm wash medium can improve the fertilization potential and preimplantation embryo development and can be considered as a safe alternate to PTX.


Subject(s)
Asthenozoospermia/drug therapy , Culture Media/chemistry , Embryonic Development/drug effects , Spermatozoa/growth & development , Animals , Asthenozoospermia/pathology , Biotin/pharmacology , Blastocyst/drug effects , Cryopreservation , Female , Fertilization/drug effects , Fertilization in Vitro/drug effects , Gene Expression Regulation, Developmental/drug effects , Glucokinase/genetics , Humans , Male , Mice , Pentoxifylline/pharmacology , Pregnancy , Protein Tyrosine Phosphatase, Non-Receptor Type 1/genetics , Sperm Motility/drug effects , Spermatozoa/drug effects
7.
Endocrinology ; 163(9)2022 09 01.
Article in English | MEDLINE | ID: mdl-35776497

ABSTRACT

Polycystic ovarian syndrome (PCOS) is a complex health condition associated with metabolic disturbances and infertility. Recent data suggest that the prevalence of PCOS is increasing among women globally, although the etiology of these trends is undefined. Consequently, preclinical models that better reflect the biology of PCOS are urgently needed to facilitate research that can lead to the discovery of prevention strategies or improved management. The existing animal models have several limitations as they do not reflect all the PCOS features metabolically and/or phenotypically. Therefore, there is no clear consensus on the use of appropriate animal model and selection of the most appropriate PCOS-inducing agent. To that end, we have established a Swiss albino mouse model of PCOS based on 3 weeks of daily treatment with letrozole (50 µg/day; intraperitoneal) and dehydroepiandrosterone (DHEA, 6 mg/100 g body weight; subcutaneous) in 5-week-old female mice fed on normal or high-fat diet (HFD). Mice were regularly assessed for body weight, blood glucose, and estrous cycle. Three weeks after drug administration, mice were sacrificed and assessed for blood-based metabolic parameters as well as ovarian function. Our results indicate that DHEA combined with HFD produces changes mimicking those of clinical PCOS, including elevated serum testosterone and luteinizing hormone, dyslipidemia, poor ovarian microenvironment, and development of multiple ovarian cysts, recapitulating cardinal features of PCOS. In comparison, normal diet and/or letrozole produced fewer features of PCOS. The data from the experimental models presented here can improve our understanding of PCOS, a growing concern in women's health.


Subject(s)
Polycystic Ovary Syndrome , Animals , Body Weight , Dehydroepiandrosterone , Diet, High-Fat/adverse effects , Disease Models, Animal , Female , Humans , Letrozole , Mice , Polycystic Ovary Syndrome/metabolism , Tumor Microenvironment
8.
J Ethnopharmacol ; 259: 112922, 2020 Sep 15.
Article in English | MEDLINE | ID: mdl-32422360

ABSTRACT

ETHNOPHARMACOLOGICAL RELEVANCE: Moringa oleifera Lam. is known for its nutritional and ethno medicinal values due to the presence of wide array of phytochemicals with multiple biological activities. We have previously reported that ethanolic extract of Moringa oleifera leaves (MOE) ameliorated cyclophosphamide (CP)-induced testicular toxicity and improved functional integrity of spermatozoa as well as spermatogenic cells. AIM OF THE STUDY: The present study was planned to investigate whether the mitigation of CP-induced testicular toxicity by MOE is mediated via modulation of endocrine profile, genes associated with function of different cell types and enhancement of DNA repair response in spermatogonial cells. MATERIALS AND METHODS: Adult Swiss albino mice (8 week) were injected with CP (100 mg/kg, one dose in a week for 3 weeks) and MOE (100 mg/kg, 5 doses in a week for 4 weeks) either alone or in combination intraperitoneally. At 35 day post CP injection (first dose), the functional characteristics such as count, motility, head morphology and DNA integrity were assessed in epididymal spermatozoa. Key reproductive hormones like testosterone, follicle stimulating hormone (FSH) and Inhibin B concentration were analyzed in serum and testis. In addition, mRNA expression of genes pertaining to the function of Leydig, Sertoli and spermatogonial cells as well as antioxidant enzymes were evaluated in the testis. To understand the DNA damage and repair process in germ cells, prepubertal (2 week) mice were administered with single dose of CP (200 mg/kg) and/or MOE (100 mg/kg) and analyzed for expression of DNA damage (γ-H2AX, P53 and Caspase3) and repair genes (Rad51 and Ku80) in isolated spermatogonial cells at various time points after treatment. RESULTS: CP administration resulted in decrease in count, motility and increase in morphological defects and DNA damage in spermatozoa. Testosterone level was marginally decreased while there was a significant increase in FSH (p < 0.001) and decrease in inhibin B (p < 0.05) observed in CP treated mice. Administration of MOE prior to CP, improved sperm functional characteristics, decreased FSH and increased inhibin B levels. Expression of Abp was down-regulated while Transferrin, Fshr and Gata4 (Sertoli cell specific genes) were up-regulated in testis treated with CP. Administration of CP down-regulated the expression of Oct4 and Ddx4 (Spermatogonia specific genes). MOE administration was shown to ameliorate CP-induced damage by modulating the expression of genes specific to Sertoli and spermatogenic cells. Furthermore, MOE treatment reduced CP-induced DNA damage as evident from lower percentage of γ-H2AX positive spermatogonial cells. CONCLUSION: Administration of MOE mitigated CP-induced testicular damage by improving blood and, intra-testicular hormonal milieu as well as modulating the expression of genes pertaining to Sertoli and spermatogonial cells.


Subject(s)
Gene Expression/drug effects , Moringa oleifera , Plant Extracts/pharmacology , Testis/metabolism , Animals , Cyclophosphamide , DNA Damage/drug effects , DNA-Binding Proteins/metabolism , Follicle Stimulating Hormone/blood , Histones/metabolism , Inhibins/metabolism , Male , Mice , Plant Leaves , RNA-Binding Proteins/metabolism , Sertoli Cells/metabolism , Spermatogenesis/drug effects , Spermatogonia/cytology , Spermatozoa/metabolism , Testosterone/blood
9.
Environ Toxicol Pharmacol ; 73: 103292, 2020 Jan.
Article in English | MEDLINE | ID: mdl-31765964

ABSTRACT

Prepubertal Swiss albino mice of both sex were administered with first-line anti-tuberculosis drugs (ATDs) viz; rifampicin, isoniazid, pyrazinamide, streptomycin and ethambutol intraperitoneally, for 4 weeks. Two weeks after the completion of treatment, male mice were sacrificed to collect caudal spermatozoa and female mice were superovulated with pregnant mare serum gonadotropin (PMSG) and human chorionic gonadotropin (hCG) to collect metaphase II (MII) oocytes from oviduct. Administration of ATDs not only decreased the count, motility and, nuclear maturity and also, increased the head abnormalities, mitochondrial damage and DNA damage in epididymal spermatozoa. Reduction in number of ovulated oocytes, increased degeneration rate and altered distribution pattern of cytoplasmic organelles was observed in oocytes of female mice. Presence of ATDs in in vitro maturation (IVM) medium increased abnormalities in meiotic resulted in abnormal spindle organization (except ethambutol) without affecting nuclear maturation. In conclusion, the result of this study indicates that ATDs have considerable adverse effects on the functional competence of male and female gametes, however, with varied degree of toxicity.


Subject(s)
Antitubercular Agents/toxicity , Oocytes/drug effects , Spermatozoa/drug effects , Animals , Cell Nucleus , Ethambutol/toxicity , Female , Isoniazid/toxicity , Male , Metaphase , Mice , Pharmaceutical Preparations , Pregnancy , Pyrazinamide/toxicity , Rifampin/toxicity , Streptomycin/toxicity
10.
Biomed Pharmacother ; 95: 252-263, 2017 Nov.
Article in English | MEDLINE | ID: mdl-28846983

ABSTRACT

Development of excellent curative therapy for most of the malignancies has resulted in a growing population of cancer survivors who are at increased risk for a variety of health problems including infertility. Therefore, fertility preservation has become an important issue during cancer treatment in recent years. Combination therapy with natural agents such as vitamins, antioxidants, dietary supplements, and plant products are considered as an attractive option to mitigate normal tissue toxicity imparted by chemotherapy. The aim of the present study was to explore the beneficial effect of hydroethanolic extract of Indian propolis (HEIP) on mitigating mitomycin C (MMC)-induced testicular damage and its mechanism of action. Healthy adult male mice were injected intraperitoneally with saline, MMC, HEIP and HEIP followed by MMC after 1h. The animals were dissected at 35days after various treatments to analyze testicular function. MMC administration resulted in significant reduction in testicular function in a dose-dependent manner at 35days after treatment which significantly improved by HEIP pre-treatment. At 24h after treatment, MMC induced significant increase in oxidative stress, γ-H2AX foci and expression of RAD51 and KU80 in testicular cells. Prior treatment with HEIP decreased the oxidative stress, reduced DNA damage and restored the testicular testosterone and inhibin B level. In conclusion, co-administration of Indian propolis extract may play a promising beneficial role in fertility preservation of males undergoing chemotherapy.


Subject(s)
Antioxidants/metabolism , DNA Damage/drug effects , Mitomycin/toxicity , Propolis/pharmacology , Testis/drug effects , Testis/metabolism , Animals , DNA Damage/physiology , India , Male , Mice , Propolis/isolation & purification , Spermatozoa/drug effects , Spermatozoa/metabolism , Spermatozoa/pathology , Testis/pathology
11.
J Ethnopharmacol ; 182: 101-9, 2016 Apr 22.
Article in English | MEDLINE | ID: mdl-26875643

ABSTRACT

ETHNOPHARMACOLOGICAL RELEVANCE: Moringa oleifera Lam. is widely cultivated in Asian and African countries for its medicinal and dietary significance. The leaves are highly nutritious and are known to possess various biological activities. MATERIALS AND METHODS: Pre-pubertal Swiss albino male mice were injected with single dose of cyclophosphamide (CP, 200mg/kg body weight) or ethanolic extract of Moringa oleifera leaves (MOE, 100mg/kg body weight) intraperitoneally. In combination group, MOE was administered 24h prior to CP injection. RESULTS: CP induced a significant decrease in testicular weight (p<0.01) and depletion of germ cells (p<0.001) and higher level of DNA damage (p<0.001) compared to control. The expression of P53, Bax, Cytochrome C (Cyt C) was increased while there was a decrease in the expression of Bcl2, c-Kit and Oct4. Administration of MOE 24h prior to CP treatment ameliorated the depletion (p<0.001), DNA damage (p<0.001) and apoptosis (p<0.01) of germ cells induced by CP. The mitigating effect of MOE appears to be mediated by up-regulating the expression of c-Kit and Oct4 transcripts in P53-independent manner. CONCLUSION: MOE protects the spermatogonial cells from CP-induced damage by modulating the apoptotic response elicited by CP and therefore can be considered as an efficient method of male fertility preservation.


Subject(s)
Cyclophosphamide/toxicity , Moringa oleifera , Plant Extracts/pharmacology , Protective Agents/pharmacology , Spermatogonia/drug effects , Animals , Cytochromes c/genetics , DNA Damage , Ethanol/chemistry , Male , Mice , Octamer Transcription Factor-3/genetics , Plant Leaves/chemistry , Proto-Oncogene Proteins c-bcl-2/genetics , Proto-Oncogene Proteins c-kit/genetics , RNA, Messenger/metabolism , Sexual Development , Solvents/chemistry , Sperm Count , Spermatogonia/metabolism , Spermatogonia/pathology , bcl-2-Associated X Protein/genetics
12.
Environ Toxicol Pharmacol ; 47: 28-37, 2016 Oct.
Article in English | MEDLINE | ID: mdl-27579587

ABSTRACT

The present study reports the effect of ethambutol (EMB) on testicular function. Prepubertal and adult male Swiss albino mice were treated with 40, 80, 160mg/kg body weight of EMB, intraperitoneally, every alternate day for 4 weeks. After 2 weeks gap, mice were sacrificed to collect caudal spermatozoa. EMB treatment resulted in a dose-dependent decrease in the testicular weight, sperm count and motility while the percentage of sperm with head abnormalities, immature chromatin (P<0.001) and DNA damage increased (P<0.01). In addition, EMB treatment resulted in significant depletion of glutathione (P<0.05-P<0.01) and histopathological abnormalities such as large cells, vacuolation of tubules and isolated colonies of spermatogenic cells were observed. Oct4, 17ß-Hsd and c-Kit mRNA was marginally elevated in EMB treated testes at the highest dose studied. In conclusion, the result of the present study indicates that EMB has adverse effect on testicular function and impairs the sperm functional competence.


Subject(s)
Ethambutol/adverse effects , Spermatozoa/drug effects , Testis/drug effects , Animals , Bone Marrow/drug effects , Bone Marrow/pathology , Chromatin/drug effects , DNA Damage/drug effects , Gene Expression Regulation/drug effects , Glutathione/metabolism , Lipid Peroxidation/drug effects , Male , Mice , Mitochondrial Membranes/drug effects , Organ Size/drug effects , Sperm Motility/drug effects , Spermatozoa/pathology , Testis/pathology , Testis/physiology , Testosterone/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL